SHANGHAI FUDAN FORWARD S&T CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.11 CNY | -3.07% |
|
+1.48% | -28.02% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 789M 109M | Sales 2023 | 680M 94.29M | Capitalization | 3.88B 538M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -416K | Net income 2023 | 5M 694K | EV / Sales 2022 | 5.19 x |
| Net Debt 2022 | 207M 28.7M | Net Debt 2023 | 211M 29.3M | EV / Sales 2023 | 6.02 x |
| P/E ratio 2022 |
-1,078
x | P/E ratio 2023 |
634
x | Employees | 1,426 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.07% | ||
| 1 week | +1.48% | ||
| 1 month | -12.74% | ||
| 3 months | -0.96% | ||
| 6 months | -30.10% | ||
| Current year | -28.02% |
1 week
4.03
4.22
1 month
3.674.75
Current year
3.675.95
1 year
3.676.66
3 years
3.678.07
5 years
3.6714.20
10 years
3.6717.96
| Managers | Title | Age | Since |
|---|---|---|---|
Zhi Bin Yu
IRC | Investor Relations Contact | - | - |
Yue Zhuang
PRN | Corporate Officer/Principal | 40 | 20-12-07 |
Min Shen
SEC | Corporate Secretary | 46 | 00-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Qian
BRD | Director/Board Member | 61 | 20-12-07 |
Yue Zhuang
PRN | Corporate Officer/Principal | 40 | 20-12-07 |
Yan Lu
BRD | Director/Board Member | 43 | 20-12-07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.67% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 4.11 | -3.07% | 8,226,090 |
| 24-04-29 | 4.24 | +4.69% | 5,880,381 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
SHANGHAI FUDAN FORWARD S&T CO., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's pharmaceuticals include digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, immune function medications and others. The Company is also engaged in the provision of financial insurance software products. It distributes its products within domestic markets and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-06-05
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -28.02% | 386M | |
| +21.41% | 43.48B | |
| +20.67% | 22.65B | |
| +14.01% | 14.73B | |
| +14.21% | 13.79B | |
| +48.11% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
- Stock Market
- Equities
- 600624 Stock